When ideology overtakes pragmatism in crafting public policies, it portends danger to society. The recent decision by the ...

Biosergen AB ("Biosergen" or the "Company") hereby publishes the interim report for the second quarter 2025. The interim report is available as an attached document and on the ...

Bristol Myers Squibb (BMY) and GSK PLC (GSK) are among the largest global biopharma companies with broad and diverse ...

GSK and Hengrui Pharma signed a global deal for up to 12 drugs, including COPD therapy, with milestone payments totaling $12 billion.

Having scored approval for Nucala in COPD, GSK has signed a $12 billion deal to strengthen the pharma’s offering for the respiratory condition.

GSK’s cobolimab has become the latest anti-TIM-3 antibody to flunk a crucial oncology test, as the pharma absorbs a more than $600 million hit from its anti-TIGIT drug failure.

British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority ...

AbbVie, Gilead and GSK marked World Hepatitis Day on Monday, outlining the need to tackle the stigma and discrimination associated with the viruses.

GSK is paying $500M upfront for rights to a series of Hengrui drugs, the latest case of a pharma company looking to a Chinese firm to build out its pipeline.

Today's biotech news cover the FDA delaying GSK's Blenrep decision again, Tessera cutting jobs amid financial challenges, and more.

The pharmaceutical drug delivery market is entering a transformative phase, projected to grow from USD 1,949.4 billion in ...

The Indian unit of British drugmaker GSK Plc reported a 2% decline in its revenue from operations to 8.05 billion rupees ($92 million)for the first quarter ended June 30. GlaxoSmithKline Pharma said ...